Tecogen (Tecogen) Total Current Assets : $19.73 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Tecogen Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Tecogen's total current assets for the quarter that ended in Mar. 2024 was $19.73 Mil.

Tecogen Total Current Assets Historical Data

The historical data trend for Tecogen's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tecogen Total Current Assets Chart

Tecogen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Current Assets

Get a 7-Day Free Trial

27.91

22.19

24.98

22.03

20.31

Tecogen Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Current Assets	Get a 7-Day Free Trial															22.35	21.78	21.60	20.31	19.73

Tecogen Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Tecogen's Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	1.351	+	8.04	+	10.553	+	0.361
	=	20.31

Tecogen's Total Current Assets for the quarter that ended in Mar. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	1.51	+	7.792	+	10.021	+	0.41
	=	19.73

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Tecogen (OTCPK:TGEN) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Tecogen's Liquidation Value for the quarter that ended in Mar. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1.51	-	14.849	+	0.75 * 6.533	+	0.5 * 10.021
=	-3.43

Tecogen Total Current Assets Related Terms

Thank you for viewing the detailed overview of Tecogen's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Tecogen (Tecogen) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Tecogen Inc (OTCPK:TGEN) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

2T1:Germany

Address

45 First Avenue, Waltham, MA, USA, 02451

Website

https://www.tecogen.com

Tecogen Inc, designs, manufactures, markets, and maintains high efficiency, ultra-clean cogeneration products. It operates in three business segments, namely Products, Services and Energy Production. Products segment designs, manufactures and sells industrial and commercial cogeneration systems. Services segment provides operations and maintenance services and turn-key installation for products under long term service contracts. Energy Production segment sells energy in the form of electricity, heat, hot water and cooling to the customers under long-term energy sales agreements.

Executives

Earl R Lewis	director	C/O NXSTAGE MEDICAL INC. (NXTM), 439 SOUTH UNION STREET, 5TH FLOOR, LAWRENCE MA 01843
John Hatsopoulos	director, 10 percent owner, officer: Chief Executive Officer	85 FIRST AVENUE, WALTHAM MA 02451
Susan B Hirsch	director	280 OLD SOMERSET ROAD, WATCHUNG NJ 07069
Abinand Rangesh	director, officer: Chief Financial Officer	45 FIRST AVE, WALTHAM MA 02451
John M Albertine	director	100 FEDERAL DRIVE, FREDERICKSBURG VA 22405
Pacheco Ann Marie Brown	10 percent owner, other: Trustee	C/O TECOGEN INC., 45 FIRST AVE., WALTHAM MA 02451
Ralph Jenkins	director	45 FIRST AVE, WALTHAM MA 02451
Fred Holubow	director
Locke M. Benjamin	officer: Co-CEO	45 FIRST AVE, WALTHAM MA 02451
Whiting John Kimball Iv	officer: General Counsel & Secretary	49 L STREET, UNIT 9, BOSTON MA 02127
Deanna M Petersen	director	45 FIRST AVENUE, WALTHAM MA 02451
Yiannis Monovoukas	10 percent owner	TEI BIOSCIENCES, INC., 7 ELKINS STREET, BOSTON MA 02127
Charlest Maxwell	director	6100 NORTH WESTERN AVE, OKLAHOMA CITY OK 73118
Keith Davidson	director	C/O TECOGEN INC., 45 FIRST AVE., WALTHAM MA 02451
David A Garrison	officer: CFO, Treasurer and Secretary	C/O ARRHYTHMIA RESEARCH TECHNOLOGY INC., 25 SAWYER PASSWAY, FITCHBURG MA 01420